SCHEMBL258635

SCHEMBL258635

C1CCC2CNCC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475059 1.00
SCHEMBL1025624 1.00
SCHEMBL31518161 1.00
SCHEMBL6673550 1.00
SCHEMBL9295522 1.00
SCHEMBL8542060 1.00
SCHEMBL10754844 0.96 CCR5 (0.53)
SCHEMBL21440674 0.96 CCR5 (0.53)
SCHEMBL18155356 0.96 CCR5 (0.53)
SCHEMBL21349622 0.96 CCR5 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022096-A1 NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS GENECODE (EE) 2026-01-22 US claimed
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US claimed
EP-4561994-A1 NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS Genecode (EE) 2025-06-04 EP claimed
US-20250154109-A1 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC 2025-05-15 US claimed
CN-119959406-A Method for detecting cis-all-hydrogen isoindole and trans-isomer in salt thereof 北京四环科宝制药股份有限公司 2025-05-09 CN claimed
CN-119948015-A Novel sulfonamides and their use as neuroprotective and/or nerve repair agents 基因密码公司 2025-05-06 CN claimed
US-12269808-B2 Amino dithioperacid thioester compound, preparation method therefor, and use thereof FUDAN UNIVERSITY (CN) 2025-04-08 US claimed
WO-2025029890-A1 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2025-02-06 WO claimed
EP-4472966-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2024-12-11 EP claimed
CN-118772029-A Anti-atopic dermatitis active enaminones compound, preparation and application thereof 中国医学科学院药物研究所 2024-10-15 CN claimed
EP-0214570-A2 N-alkylated tripeptides, process for their preparation, medicaments containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-18 EP claimed
EP-0190058-A1 Peptide derivatives with a polycyclic nitrogen structure, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1986-08-06 EP claimed
EP-0158927-A2 Process for the treatment of heart failure HOECHST AKTIENGESELLSCHAFT (DE) 1985-10-23 EP claimed
EP-0158157-A1 Method for the treatment of glaucoma HOECHST AKTIENGESELLSCHAFT (DE) 1985-10-16 EP claimed
US-4525301-A REACTING TRIFLUOROMETHANE SULFONIC ACID DERIVATIVES WITH AMINO ACID ESTERS HOECHST AKTIENGESELLSCHAFT (DE) 1985-06-25 US claimed
EP-0135182-A2 Process for the production of N-alkylated dipeptides and of their esters HOECHST AKTIENGESELLSCHAFT (DE) 1985-03-27 EP claimed
EP-0135181-A2 Process for the production of N-alkylated dipeptides and of their esters HOECHST AKTIENGESELLSCHAFT (DE) 1985-03-27 EP claimed
EP-0126986-A1 Process for producing N-alkylated dipeptides and their esters HOECHST AKTIENGESELLSCHAFT (DE) 1984-12-05 EP claimed
EP-0023569-B1 DERIVATIVES OF CARBOXYLIC ACIDS, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1983-06-22 EP claimed
EP-0023569-A1 Derivatives of carboxylic acids, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1981-02-11 EP claimed